Xanthohumol and Gossypol Are Promising Inhibitors against <i>Babesia microti</i> by In Vitro Culture via High-Throughput Screening of 133 Natural Products
Human babesiosis caused by <i>Babesia microti</i> is an emerging threat for severe illness and even death, with an increasing impact worldwide. Currently, the regimen of atovaquone and azithromycin is considered as the standard therapy for treating human babesiosis, which, however, may r...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-10-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/8/4/613 |